Formulation guide · ZLEY Group
Source check: 30 October 2026. Grade information comes from the linked supplier product brief. Suggested experiments require project-specific design. Encapsulation does not establish finished-product stability, tolerance or market compliance.
Water-dispersible encapsulated retinol can provide a route for developing a water-containing serum, but it does not remove the need for careful process and stability work. The active, carrier and complete formula must remain compatible through manufacturing, storage and dispensing. This guide uses ZLEY®VA ENVOVA 2% to explain how to evaluate a supplied delivery system, calculate nominal retinol content and prepare a meaningful sample trial.
Water-dispersible retinol is not the same as water-soluble retinol
A dispersion distributes the supplied delivery system within the formula. Dissolution describes a different physical state. A uniform-looking dispersion does not establish molecular dissolution, transparent appearance or indefinite physical stability. This distinction matters when the brief requires a clear serum: the behavior of a delivery system needs to be assessed in the actual base rather than inferred from the word “water.”
Encapsulation describes a delivery approach, not a universal performance result. The complete formula can influence the carrier structure, active availability, particle behavior and appearance. Surfactants, electrolytes, solvents, polymers and processing conditions may affect the outcome. Evaluate the supplied system as a multi-ingredient material with its own instructions instead of handling it as neat retinol powder.
Begin by defining the desired product: clear gel, translucent serum, opaque lotion or another format. State the sensory targets, packaging, intended use and available equipment. These constraints help determine whether this dispersion is a useful starting point or whether another retinoid architecture should be evaluated. A clear design brief also makes technical support more specific.
Published ZLEY VA ENVOVA 2% information
| Parameter | Published information | What to verify |
|---|---|---|
| INCI | Retinol, Caprylic/Capric Triglyceride, Polyglyceryl-10 Myristate, Hydrogenated Lecithin, Tocopherol, 1,2-Hexanediol, Glycerin, Water | Current composition and labeling information for the supplied grade. |
| Retinol content | Nominal 2% in the supplied blend | Batch assay, method and specification basis. |
| Appearance | Pale yellow to yellow viscous liquid | Incoming specification and allowable variation. |
| Suggested blend use level | 1–20% in the product brief | Final active level, product category and destination-market assessment. |
| Incorporation | Room-temperature incorporation in the product information table; aqueous pre-dispersion and addition below 50°C with homogenization in example T25082801 | Controlled process instructions, equipment settings and residence time. |
| Finished-formula pH | No universal range established here | Request the current grade-specific recommendation and validate the final system. |
The blend contains ingredients beyond retinol. At a substantial blend addition, those components can influence the oil fraction, humectant level, sensory properties and preservation environment. Include the full supplied composition in development calculations. Do not count a 2% blend as 2% pure retinol, and do not use the nominal retinol content to infer the concentration of every other component.
Calculate the nominal retinol contribution
Nominal retinol percentage in the finished formula equals supplied-blend percentage multiplied by 0.02 when the blend contains 2% retinol by mass. A 5% addition therefore contributes 0.10% nominal retinol. This is an arithmetic illustration, not a dose recommendation or a finding that the resulting product is appropriate for any particular consumer or market.
| Blend in finished formula | Calculation | Nominal retinol |
|---|---|---|
| 1% | 1% × 0.02 | 0.02% |
| 5% | 5% × 0.02 | 0.10% |
| 10% | 10% × 0.02 | 0.20% |
| 20% | 20% × 0.02 | 0.40% |
The upper end of a supplier’s suggested blend range is not a universal finished-product permission. Have the final active concentration, product category, target population, labeling and intended markets assessed before commercialization. The table describes mass balance only. Encapsulation does not exempt retinol from applicable assessment, and another ingredient’s use restriction should not be assumed to apply identically to this blend.
At the laboratory stage, record both the amount of supplied blend and the calculated active contribution. Confirm the assay basis with the supplier and account for any other retinol-containing ingredients. Avoid adding an arbitrary overage to compensate for suspected degradation: establish an analytically justified development plan and assess the initial concentration as well as the end-of-storage result.
A controlled bench process for a water-containing serum
Start with a base that has already demonstrated acceptable physical behavior without the retinol delivery system. This creates a useful reference when appearance or viscosity changes after addition. Record the water quality, polymer hydration procedure, pH adjustments and other actives. A dispersion trial is difficult to interpret if the base itself is still changing during equilibration.
The product information table describes room-temperature incorporation. The example formula T25082801 describes pre-dispersion in water, addition below 50°C and homogenization. These statements have different scopes: an example process is not a universal maximum-temperature specification. Confirm the current controlled instructions before use. Rotor design, vessel geometry, batch size and mixing time determine the actual treatment. Ask for equipment guidance and define effective mixing conditions for a uniform batch.
- Prepare and characterize the base, retaining a sample without the retinol blend.
- Verify the batch identity and calculate the supplied-blend amount from the intended active target.
- Pre-disperse using the agreed water portion and supplier procedure, then inspect for uniformity.
- Confirm the actual batch temperature before addition and record the time-temperature history.
- Mix under the validated conditions, inspect after equilibration and sample from representative locations.
- Fill trial packaging and start the agreed analytical and physical stability program.
Avoid assuming that a different encapsulated retinol grade’s instructions apply here. Some delivery systems tolerate processing that others do not. If your base requires a high-temperature or high-shear step, investigate whether it can be completed before introducing this material. A process change still needs validation, including uniform incorporation and the effect on the final texture.
Compatibility with polymers, electrolytes and other actives
Evaluate the intended thickener, emulsifier, fragrance and preservation system together with the blend. Look for delayed viscosity loss, aggregation, sediment, separation and changes in dispensing. A short-term jar observation may miss a problem that develops after a temperature cycle or several weeks of storage. Define observation intervals and retain controls so that changes can be traced.
When combining retinol with niacinamide, peptides or botanical materials, avoid treating a familiar pairing as automatic proof of compatibility. Each commercial ingredient may introduce its own carrier, electrolyte load or preservation package. Screen a simple formula first, then add complexity in stages where practical. If a problem appears, compare the complete blend with an appropriate base control before assigning a cause.
Measure pH using a consistent method where applicable, after the formula has equilibrated. Follow the current supplier recommendation and verify the chosen range against the entire system. Retinol assay, dispersion behavior and preservative performance all matter. Selecting a convenient pH solely because another product uses it is insufficient for a manufacturing specification.
Chemical stability and physical dispersion need separate checks
A stable-looking serum may have lost retinol, while a chemically acceptable sample may show unacceptable particle behavior or texture. Include both active assay and physical observations. Use an analytical method with suitable extraction and recovery for the encapsulated matrix; otherwise, an apparent loss may reflect sample preparation rather than the amount present.
| Area | Useful measurements | Decision supported |
|---|---|---|
| Chemical stability | Initial and stored retinol assay; relevant degradation observations | Whether the active remains within justified criteria. |
| Dispersion and texture | Appearance, viscosity, separation, microscopy or particle analysis where suitable | Whether the delivery system and base remain physically compatible. |
| Microbiology | Microbial quality and applicable preservative efficacy evaluation | Whether the complete preservation design is adequate. |
| Packaging and use | Dispensing consistency, pack interaction, leakage and in-use exposure | Whether the selected commercial pack supports the product. |
| Tolerance and claims | Appropriate finished-product testing and review | Which consumer-facing statements the evidence supports. |
Define the protocol and acceptance criteria before reviewing the results. Consider project-specific accelerated conditions, real-time storage and realistic handling. A single stress test does not establish shelf life. If a temperature condition creates a change, investigate whether it is reversible and whether it represents a relevant risk for transport or consumer storage.
Packaging, dispensing and production scale
Evaluate the actual commercial packaging, including repeated dispensing and product remaining near the outlet. Compare candidate packs with a suitable reference. Light-protective or airless packaging may be useful options, but the label on the pack does not prove active retention or compatibility. Contact materials, headspace, filling conditions and consumer handling can all influence the result.
During scale-up, examine mixing uniformity without assuming that more shear is better. Record equipment configuration, addition rate and hold times. Sample representative vessel locations and the filled batch where appropriate. A process that appears uniform at the surface can still produce variation during transfer or filling, so define the observations that support batch release.
How to assess controlled-release and sensitive-skin claims
Ask for the specific study behind a delivery-system claim: tested material, active concentration, vehicle, comparator, method and measured endpoint. A release experiment, an instrumental measurement and a human tolerance study answer different questions. Evidence about the raw material does not automatically establish the result in a new serum after its processing and storage history.
Do not infer universal sensitive-skin suitability from encapsulation alone. Evaluate the final formula and intended use with appropriate expertise and testing. Likewise, avoid presenting an ingredient brochure as independent confirmation of finished-product efficacy. A precise account of what was tested is more useful to a formulator or buyer than a broad promise of superior results.
What to send when requesting samples and technical data
Include your intended format, appearance target, nominal retinol level, batch size, mixing equipment, process temperature, pH target where applicable, destination market and packaging. Request the current TDS, SDS, batch COA, assay method, storage conditions, shelf life and available process or study protocols. Confirm sample availability, MOQ and commercial lead time through the technical and sales teams.
If troubleshooting, send the formulation version, addition sequence, temperature history and dated observations. Describe whether the concern is active loss, physical instability, texture or packaging behavior. These details let the technical team identify the next informative comparison and determine which document or trial would resolve the uncertainty.
Request encapsulated retinol samples / technical data
Formulation FAQ
Is water-dispersible encapsulated retinol the same as dissolved retinol?
No. A dispersion distributes the supplied delivery system through the formula. It does not demonstrate molecular dissolution, optical clarity or compatibility with every aqueous serum.
How do I calculate active retinol from a 2% blend?
Multiply the blend use level by its verified retinol fraction. For a nominal 2% retinol blend, 5% blend gives 0.10% nominal retinol in the finished formula. Confirm the batch assay and regulatory assessment before selecting a commercial dose.
How should ZLEY VA ENVOVA 2% be incorporated?
The product information table describes room-temperature incorporation. Example formula T25082801 uses aqueous pre-dispersion and addition below 50°C followed by homogenization. Confirm the current controlled instructions and validate the actual equipment, residence time and complete formula.
Source and scope
ZLEY VA ENVOVA 2% supplier product brief: supplied composition, nominal retinol content, suggested blend range and incorporation instructions. Request the current controlled TDS, SDS and lot-specific COA before scale-up. The trial designs and arithmetic examples above do not establish a commercial dose, shelf life or clinical result.
Technical review, sources and testing
Sources and controlled documents
Testing and evidence note
Published supplier document facts are identified in the guide. Bench workflows and calculations are proposed evaluation tools, not completed test results, clinical validation or target-market regulatory clearance. Obtain current controlled documents and validate the finished formulation.
